Personalized medicine: Genetic diagnosis for inherited cardiomyopathies/ channelopathies;Medicina personalizada: diagnóstico genético de cardiopatías/canalopatías hereditarias

Revista Espanola de Cardiologia

Volumn 66, Issue 4, 2013, Pages 298-307

  Ackerman, Michael J ^a   Marcou, Cherisse A ^a   Tester, David J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cardiomyopathy; Channelopathies; Genetics; Ion channels

Indexed keywords

ARTICLE; CARDIOMYOPATHY; CHANNELOPATHY; GENETIC DISORDER; GENETIC SCREENING; HEART DISEASE; MEDICAL GENETICS; PERSONALIZED MEDICINE; CARDIOMYOPATHIES; CHANNELOPATHIES; GENETIC COUNSELING; GENETICS; HUMAN; TRENDS;

CARDIOMYOPATHIES; CHANNELOPATHIES; GENETIC COUNSELING; GENETIC TESTING; HUMANS; INDIVIDUALIZED MEDICINE;

EID: 84937675870     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2012.12.010     Document Type: Article

References (76)

1. R.E. Hershberger, A. Morales, and J.D. Siegfried Clinical and genetic issues in dilated cardiomyopathy: a review for genetics professionals Genet Med 12 2010 655 667
2. J.D. Kapplinger, A.P. Landstrom, B.A. Salisbury, T.E. Callis, G.D. Pollevick, and D.J. Tester Distinguishing arrhythmogenic right ventricular cardiomyopathy/dysplasia-associated mutations from background genetic noise J Am Coll Cardiol 57 2011 2317 2327
3. M. Ackerman, S. Priori, S. Willems, C. Berul, R. Brugada, and H. Calkins HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA) Heart Rhythm 8 2011 1308 1339
4. M.J. Ackerman, A. Khositseth, D.J. Tester, and P.J. Schwartz Congenital long QT syndrome in electrical diseases of the heart; genetics mechanisms, treatment, prevention 2008 Springer Nueva York p. 462-82
5. S. Viskin, U. Rosovski, A.J. Sands, E. Chen, P.M. Kistler, and J.M. Kalman Inaccurate electrocardiographic interpretation of long QT: the majority of physicians cannot recognize a long QT when they see one Heart Rhythm 2 2005 569 574
6. Y. Ruan, N. Liu, C. Napolitano, and S.G. Priori Therapeutic strategies for long-QT syndrome: does the molecular substrate matter? Circ Arrhythm Electrophysiol 1 2008 290 297
7. M. Arnestad, L. Crotti, T.O. Rognum, R. Insolia, M. Pedrazzini, and C. Ferrandi Prevalence of long-QT syndrome gene variants in sudden infant death syndrome Circulation 115 2007 361 367
8. D.J. Tester, A. Medeiros-Domingo, M.L. Will, C.M. Haglund, and M.J. Ackerman Cardiac channel molecular autopsy: insights from 173 consecutive cases of autopsy-negative sudden unexplained death referred for postmortem genetic testing Mayo Clin Proc 87 2012 524 539
9. v1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism Cell 119 2004 19 31
10. L. Zhang, D.W. Benson, M. Tristani-Firouzi, L.J. Ptacek, R. Tawil, and P.J. Schwartz Electrocardiographic features in Andersen-Tawil syndrome patients with KCNJ2 mutations: characteristic T-U-wave patterns predict the KCNJ2 genotype Circulation 111 2005 2720 2726
11. P.J. Mohler, J.J. Schott, A.O. Gramolini, K.W. Dilly, S. Guatimosim, and W.H. DuBell Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death Nature 421 2003 634 639
12. D.J. Tester, M.L. Will, C.M. Haglund, and M.J. Ackerman Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing Heart Rhythm 2 2005 507 517
13. J. Jiménez-Jáimez, L. Tercedor-Sánchez, M. Álvarez-López, E. Martínez-Espín, R. Sebastián Galdeano, and I. Almansa-Valencia Estudio genético en el síndrome de QT largo en nuestro medio Rev Esp Cardiol 64 2011 71 74
14. D.J. Tester, A.J. Benton, L. Train, B. Deal, L.M. Baudhuin, and M.J. Ackerman Prevalence and spectrum of large deletions or duplications in the major long QT syndrome-susceptibility genes and implications for long QT syndrome genetic testing Am J Cardiol 106 2010 1124 1128
15. W. Shimizu Clinical impact of genetic studies in lethal inherited cardiac arrhythmias Circ J 72 2008 1926 1936
16. A. Medeiros-Domingo, Z.A. Bhuiyan, D.J. Tester, N. Hofman, H. Bikker, and J.P. Van Tintelen The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame mutational analysis J Am Coll Cardiol 54 2009 2065 2074
17. E. Villain, I. Denjoy, J.M. Lupoglazoff, P. Guicheney, B. Hainque, and V. Lucet Low incidence of cardiac events with beta-blocking therapy in children with long QT syndrome Eur Heart J 25 2004 1405 1411
18. G.M. Vincent, P.J. Schwartz, I. Denjoy, H. Swan, C. Bithell, and C. Spazzolini High efficacy of beta-blockers in long-QT syndrome type 1: contribution of noncompliance and QT-prolonging drugs to the occurrence of beta-blocker treatment «failures» Circulation 119 2009 215 221
19. A.J. Moss, J.R. Windle, W.J. Hall, W. Zareba, J.L. Robinson, and S. McNitt Safety and efficacy of flecainide in subjects with Long QT-3 syndrome (DeltaKPQ. mutation): a randomized, double-blind, placebo-controlled clinical trial Ann Noninvasive Electrocardiol 10 4 Suppl 2005 59 66
20. A.J. Moss, W. Zareba, K.Q. Schwarz, S. Rosero, S. McNitt, and J.L. Robinson Ranolazine shortens repolarization in patients with sustained inward sodium current due to type-3 long-QT syndrome J Cardiovasc Electrophysiol 19 2008 1289 1293
21. C. Jons, A.J. Moss, C.M. Lopes, S. McNitt, W. Zareba, and I. Goldenberg Mutations in conserved amino acids in the KCNQ1 channel and risk of cardiac events in type-1 long-QT syndrome J Cardiovasc Electrophysiol 20 2009 859 865
22. W. Shimizu, A. Moss, A. Wilde, J. Towbin, M. Ackerman, and D. Tester Genotype-phenotype aspects of type 2 long QT syndrome J Am Coll Cardiol 54 2009 2052 2062
23. D. Tester, A. Medeiros-Domingo, M. Will, and M. Ackerman Unexplained drownings and the cardiac channelopathies: a molecular autopsy series Mayo Clin Proc 86 2011 941 947
24. J.M. Horner, and M.J. Ackerman Ventricular ectopy during treadmill exercise stress testing in the evaluation of long QT syndrome Heart Rhythm 5 2008 1690 1694
25. N. Liu, Y. Ruan, and S.G. Priori Catecholaminergic polymorphic ventricular tachycardia Prog Cardiovasc Dis 51 2008 23 30
26. M. Eldar, E. Pras, and H. Lahat A missense mutation in the CASQ2 gene is associated with autosomal- recessive catecholamine-induced polymorphic ventricular tachycardia Trends Cardiovasc Med 13 2003 148 151
27. N. Roux-Buisson, M. Cacheux, A. Fourest-Lieuvin, J. Fauconnier, J. Brocard, and I. Denjoy Absence of triadin, a protein of the calcium release complex, is responsible for cardiac arrhythmia with sudden death in human Hum Mol Genet 21 2012 2759 2767
28. M. Nyegaard, T. Overgaard Michael, T. Sondergaard Mads, M. Vranas, R. Behr Elijah, and L. Hildebrandt Lasse Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death Am J Hum Genet 91 2012 703 712
29. H. Kimura, J. Zhou, M. Kawamura, H. Itoh, Y. Mizusawa, and W.-G. Ding Phenotype variability in patients carrying KCNJ2 mutations Circ Cardiovasc Genet 5 2012 344 353
30. P. Berne, and J. Brugada Brugada syndrome 2012 Circulation 76 2012 1563 1571
31. L. Crotti, C.A. Marcou, D.J. Tester, S. Castelletti, J.R. Giudicessi, and M. Torchio Spectrum and prevalence of mutations involving BrS1- through BrS12-susceptibility genes in a cohort of unrelated patients referred for Brugada syndrome genetic testing: implications for genetic testing J Am Coll Cardiol 60 2012 1410 1418
32. C. Antzelevitch, G.D. Pollevick, J.M. Cordeiro, O. Casis, M.C. Sanguinetti, and Y. Aizawa Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death Circulation 115 2007 442 449
33. E. Burashnikov, R. Pfeiffer, H. Barajas-Martinez, E. Delpón, D. Hu, and M. Desai Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death Heart Rhythm 7 2010 1872 1882
34. J.P. Smits, L. Eckardt, V. Probst, C.R. Bezzina, J.J. Schott, and C.A. Remme Genotype-phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients J Am Coll Cardiol 40 2002 350 356
35. P.G. Meregalli, H.L. Tan, V. Probst, T.T. Koopmann, M.W. Tanck, and Z.A. Bhuiyan Type of SCN5A mutation determines clinical severity and degree of conduction slowing in loss-of-function sodium channelopathies Heart Rhythm 6 2009 341 348
36. P.G. Postema, C. Wolpert, A.S. Amin, V. Probst, M. Borggrefe, and D.M. Roden Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org) Heart Rhythm 6 2009 1335 1341
37. R.E. Hershberger, J. Cowan, A. Morales, and J.D. Siegfried Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy Circ Heart Fail 2 2009 253 261
38. R.E. Hershberger, J. Lindenfeld, L. Mestroni, C.E. Seidman, M.R.G. Taylor, and J.A. Towbin Genetic evaluation of cardiomyopathy - a Heart Failure Society of America practice guideline J Card Fail 15 2009 83 97
39. J.M. Bos, S.R. Ommen, and M.J. Ackerman Genetics of hypertrophic cardiomopathy: one, two, or more diseases? Curr Opin Cardiol 22 2007 193 199
40. J.M. Bos, J.A. Towbin, and M.J. Ackerman Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy J Am Coll Cardiol 54 2009 201 211
41. J. Binder, S.R. Ommen, B.J. Gersh, S.L. Van Driest, A.J. Tajik, and R.A. Nishimura Echocardiography-guided genetic testing in hypertrophic cardiomyopathy: septal morphological features predict the presence of myofilament mutations Mayo Clin Proc 81 2006 459 467
42. I. Olivotto, F. Girolami, M.J. Ackerman, S. Nistri, J.M. Bos, and E. Zachara Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy Mayo Clin Proc 83 2008 630 638
43. D.J. Tester, and M.J. Ackerman Genetic testing I. Gussak, C. Antzelevitch, Electrical diseases of the heart: genetics, mechanisms, treatment, prevention 2008 Springer Londres 444 458
44. S. Kapa, D.J. Tester, B.A. Salisbury, C. Harris-Kerr, M.S. Pungliya, and M. Alders Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants Circulation 120 2009 1752 1760
45. J. Cowan, A. Morales, J. Dagua, and R.E. Hershberger Genetic testing and genetic counseling in cardiovascular genetic medicine: overview and preliminary recommendations Congest Heart Fail 14 2008 97 105
46. The National Society for Genetic Counselors, Inc. website (NSGC) [citado Nov 2012]. Disponible en: http://www.nsgc.org
47. C.S. Ku, N. Naidoo, and Y. Pawitan Revisiting Mendelian disorders through exome sequencing Hum Genet 129 2011 351 370
48. S.B. Ng, E.H. Turner, P.D. Robertson, S.D. Flygare, A.W. Bigham, and C. Lee Targeted capture and massively parallel sequencing of 12 human exomes Nature 461 2009 272 276
49. S.B. Ng, A.W. Bigham, K.J. Buckingham, M.C. Hannibal, M.J. McMillin, and H.I. Gildersleeve Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome Nat Genet 42 2010 790 793
50. J.L. Theis, K.M. Sharpe, M.E. Matsumoto, H.S. Chai, A.A. Nair, and J.D. Theis Homozygosity mapping and exome sequencing reveal GATAD1 mutation in autosomal recessive dilated cardiomyopathy Circ Cardiovasc Genet 4 2011 585 594
51. J.R. Lupski, J.G. Reid, C. Gonzaga-Jauregui, D. Rio Deiros, D.C.Y. Chen, and L. Nazareth Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy N Engl J Med 362 2010 1181 1191
52. Hindorff LA, MacArthur J, Morales J, Junkins HA, Hall PN, Klemm AK, et al. A catalog of published genome-wide association studies [citado Nov 2012]. Disponible en: www.genome.gov/gwastudies
53. O. Companioni, F. Rodríguez Esparragón, A. Medina Fernández-Aceituno, and J.C. Rodríguez Pérez Variantes genéticas, riesgo cardiovascular y estudios de asociación de genoma completo Rev Esp Cardiol 64 2011 509 514
54. C. Newton-Cheh, M. Eijgelsheim, K.M. Rice, P.I.W. De Bakker, X. Yin, and K. Estrada Common variants at ten loci influence QT interval duration in the QTGEN Study Nat Genet 41 2009 399 406
55. A. Pfeufer, S. Sanna, D.E. Arking, M. Muller, V. Gateva, and C. Fuchsberger Common variants at ten loci modulate the QT interval duration in the QTSCD Study Nat Genet 41 2009 407 414
56. J.G. Smith, J.K. Lowe, S. Kovvali, J.B. Maller, J. Salit, and M.J. Daly Genome-wide association study of electrocardiographic conduction measures in an isolated founder population: Kosrae Heart Rhythm 6 2009 634 641
57. D.E. Arking, A. Pfeufer, W. Post, W.H. Kao, C. Newton-Cheh, and M. Ikeda A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization Nat Genet 38 2006 644 651
58. A.J. Aarnoudse, C. Newton-Cheh, P.I. De Bakker, S.M. Straus, J.A. Kors, and A. Hofman Common NOS1AP variants are associated with a prolonged QTc interval in the Rotterdam Study Circulation 116 2007 10 16
59. Z. Tan, G. Randall, J. Fan, B. Camoretti-Mercado, R. Brockman-Schneider, and L. Pan Allele-specific targeting of microRNAs to HLA-G and risk of asthma Am J Hum Genet 81 2007 829 834
60. M. Kelly, R.D. Bagnall, R.E. Peverill, L. Donelan, L. Corben, and M.B. Delatycki A polymorphic miR-155 binding site in AGTR1 is associated with cardiac hypertrophy in Friedreich ataxia J Mol Cell Cardiol 51 2011 848 854
61. K.G. Barringhaus, and P.D. Zamore MicroRNAs: regulating a change of heart Circulation 119 2009 2217 2224
62. M.V.G. Latronico, and G. Condorelli MicroRNAs and cardiac pathology Nat Rev Cardiol 6 2009 419 429
63. S. Ikeda, and W.T. Pu Expression and function of microRNAs in heart disease Curr Drug Targets 11 2010 913 925
64. v7.1 potassium channel modify disease severity in patients with type 1 long QT syndrome in an allele-specific manner Eur Heart J 33 2012 714 723
65. J.R. Giudicessi, and M.J. Ackerman Determinants of incomplete penetrance and variable expressivity in heritable cardiac arrhythmia syndromes Transl Res 161 2013 1 14
66. K. Takahashi, and S. Yamanaka Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Cell 126 2006 663 676
67. K. Takahashi, K. Tanabe, M. Ohnuki, M. Narita, T. Ichisaka, and K. Tomoda Induction of pluripotent stem cells from adult human fibroblasts by defined factor Cell 131 2007 861 872
68. J. Yu, M.A. Vodyanik, K. Smuga-Otto, J. Antosiewicz-Bourget, J.L. Frane, and S. Tian Induced pluripotent stem cell lines derived from human somatic cells Science 318 2007 1917 1920
69. J. Zhang, G.F. Wilson, A.G. Soerens, C.H. Koonce, J. Yu, and S.P. Palecek Functional cardiomyocytes derived from human induced pluripotent stem cells Circ Res 104 2009 e30 e41
70. I. Itzhaki, L. Maizels, I. Huber, L. Zwi-Dantsis, O. Caspi, and A. Winterstern Modelling the long QT syndrome with induced pluripotent stem cells Nature 471 2011 225 229
71. D. Malan, S. Friedrichs, B.K. Fleischmann, and P. Sasse Cardiomyocytes obtained from induced pluripotent stem cells with long-QT syndrome 3 recapitulate typical disease-specific features in vitro/novelty and significance Circ Res 109 2011 841 847
72. A. Moretti, M. Bellin, A. Welling, C.B. Jung, J.T. Lam, and L. Bott-Flugel Patient-specific induced pluripotent stem-cell models for long-QT syndrome N Engl J Med 363 2010 1397 1409
73. M. Yazawa, B. Hsueh, X. Jia, A.M. Pasca, J.A. Bernstein, and J. Hallmayer Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome Nature 471 2011 230 234
74. E. Matsa, D. Rajamohan, E. Dick, L. Young, I. Mellor, and A. Staniforth Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation Eur Heart J 32 2011 952 962
75. N. Yokoo, S. Baba, S. Kaichi, A. Niwa, T. Mima, and H. Doi The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells Biochem Biophys Res Commun 387 2009 482 488
76. S.R. Braam, L. Tertoolen, A. Van de Stolpe, T. Meyer, R. Passier, and C.L. Mummery Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes Stem Cell Res 4 2010 107 116